Gynecological radiotherapy

Publications from OUS - Section for gynaecological radiotherapy

76 publications found

Publications 2019

  1. Bowitz Lothe IM, Kleive D, Pomianowska E, Cvancarova M, Kure E, Dueland S, Gladhaug IP, Labori KJ (2019)
    Clinical relevance of pancreatobiliary and intestinal subtypes of ampullary and duodenal adenocarcinoma: Pattern of recurrence, chemotherapy, and survival after pancreatoduodenectomy
    Pancreatology, 19 (2), 316-324
    DOI 10.1016/j.pan.2019.01.019, PubMed 30713128
  2. Nomden CN, Pötter R, de Leeuw AAC, Tanderup K, Lindegaard JC, Schmid MP, Fortin I, Haie-Meder C, Mahantshetty U, Hoskin P, Segedin B, Bruheim K, Rai B, Huang F, Cooper R, Van Der Steen Banasik E, Van Limbergen E, Jürgenliemk-Schulz IM, EMBRACE Collaborative Group (2019)
    Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort
    Radiother Oncol, 134, 185-190
    DOI 10.1016/j.radonc.2019.02.007, PubMed 31005214

Publications 2018

  1. Bjørnelv GMW, Dueland S, Line PD, Joranger P, Fretland ÅA, Edwin B, Sørbye H, Aas E (2018)
    Cost-effectiveness of liver transplantation in patients with colorectal metastases confined to the liver
    Br J Surg, 106 (1), 132-141
    DOI 10.1002/bjs.10962, PubMed 30325494
  2. Bousquet PA, Meltzer S, Sønstevold L, Esbensen Y, Dueland S, Flatmark K, Sitter B, Bathen TF, Seierstad T, Redalen KR, Eide L, Ree AH (2018)
    Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer
    Transl Oncol, 12 (1), 76-83
    DOI 10.1016/j.tranon.2018.09.010, PubMed 30273860
  3. Boysen AK, Sørensen BS, Lefevre AC, Abrantes R, Johansen JS, Jensen BV, Schou JV, Larsen FO, Nielsen D, Taflin H, Gustavson B, Wettergren Y, Sorensen BS, Ree AH, Dueland S, Pallisgaard N, Spindler KL (2018)
    Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer
    Clin Chim Acta, 487, 107-111
    DOI 10.1016/j.cca.2018.09.029, PubMed 30240586
  4. Dueland S, Foss A, Solheim JM, Hagness M, Line PD (2018)
    Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma
    Br J Surg, 105 (6), 736-742
    DOI 10.1002/bjs.10769, PubMed 29532908
  5. Dueland S, Line PD, Hagness M, Foss A, Andersen MH (2018)
    Long-term quality of life after liver transplantation for non-resectable colorectal metastases confined to the liver
    BJS Open, 3 (2), 180-185
    DOI 10.1002/bjs5.50116, PubMed 30957065
  6. Fokdal L, Tanderup K, Pötter R, Sturdza A, Kirchheiner K, Chargari C, Jürgenliemk-Schulz IM, Segedin B, Tan LT, Hoskin P, Mahantshetty U, Bruheim K, Rai B, Kirisits C, Lindegaard JC, EMBRACE Collaborative Group (2018)
    Risk Factors for Ureteral Stricture After Radiochemotherapy Including Image Guided Adaptive Brachytherapy in Cervical Cancer: Results From the EMBRACE Studies
    Int J Radiat Oncol Biol Phys, 103 (4), 887-894
    DOI 10.1016/j.ijrobp.2018.11.006, PubMed 30419309
  7. Grut H, Revheim ME, Line PD, Dueland S (2018)
    Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation
    Nucl Med Commun, 39 (7), 621-627
    DOI 10.1097/MNM.0000000000000843, PubMed 29683930
  8. Kalanxhi E, Meltzer S, Schou JV, Larsen FO, Dueland S, Flatmark K, Jensen BV, Hole KH, Seierstad T, Redalen KR, Nielsen DL, Ree AH (2018)
    Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer
    Br J Cancer, 118 (10), 1322-1328
    DOI 10.1038/s41416-018-0085-y, PubMed 29695770
  9. Line PD, Hagness M, Dueland S (2018)
    The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases
    Can J Gastroenterol Hepatol, 2018, 8547940
    DOI 10.1155/2018/8547940, PubMed 29623266
  10. Mariathasan AB, Boye K, Giercksky KE, Brennhovd B, Gullestad HP, Emblemsvåg HL, Grøholt KK, Dueland S, Flatmark K, Larsen SG (2018)
    Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement
    Eur J Surg Oncol, 44 (8), 1226-1232
    DOI 10.1016/j.ejso.2018.03.029, PubMed 29691115
  11. Najjari Jamal D, Pötter R, Haie-Meder C, Lindegaard JC, Juergenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Wiebe E, Cooper R, Tanderup K, Kirchheiner K, EMBRACE collaborative group (2018)
    Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study
    Radiother Oncol, 127 (3), 449-455
    DOI 10.1016/j.radonc.2018.03.026, PubMed 29631933
  12. Pötter R, Tanderup K, Kirisits C, de Leeuw A, Kirchheiner K, Nout R, Tan LT, Haie-Meder C, Mahantshetty U, Segedin B, Hoskin P, Bruheim K, Rai B, Huang F, Van Limbergen E, Schmid M, Nesvacil N, Sturdza A, Fokdal L, Jensen NBK, Georg D, Assenholt M, Seppenwoolde Y, Nomden C, Fortin I et al. (2018)
    The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
    Clin Transl Radiat Oncol, 9, 48-60
    DOI 10.1016/j.ctro.2018.01.001, PubMed 29594251
  13. Smedman TM, Line PD, Guren TK, Dueland S (2018)
    Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients
    Acta Oncol, 57 (10), 1414-1418
    DOI 10.1080/0284186X.2018.1479069, PubMed 29912605
  14. Smet S, Pötter R, Haie-Meder C, Lindegaard JC, Schulz-Juergenliemk I, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van Limbergen E, Tanderup K, Kirchheiner K, EMBRACE Collaborative Group (2018)
    Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study
    Radiother Oncol, 127 (3), 440-448
    DOI 10.1016/j.radonc.2018.03.009, PubMed 29627137

Publications 2017

  1. Bakke KM, Hole KH, Dueland S, Grøholt KK, Flatmark K, Ree AH, Seierstad T, Redalen KR (2017)
    Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival
    Acta Oncol, 56 (6), 813-818
    DOI 10.1080/0284186X.2017.1287951, PubMed 28464745
  2. Frøysnes IS, Andersson Y, Larsen SG, Davidson B, Øien JT, Olsen KH, Giercksky KE, Julsrud L, Fodstad Ø, Dueland S, Flatmark K (2017)
    Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial
    Ann Surg Oncol, 24 (7), 1916-1922
    DOI 10.1245/s10434-017-5814-6, PubMed 28224367
  3. Grut H, Dueland S, Line PD, Revheim ME (2017)
    The prognostic value of 18F-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases
    Eur J Nucl Med Mol Imaging, 45 (2), 218-225
    DOI 10.1007/s00259-017-3843-9, PubMed 29026950
  4. Grut H, Solberg S, Seierstad T, Revheim ME, Egge TS, Larsen SG, Line PD, Dueland S (2017)
    Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases
    Br J Surg, 105 (3), 295-301
    DOI 10.1002/bjs.10651, PubMed 29168565
  5. Labori KJ, Guren MG, Brudvik KW, Røsok BI, Waage A, Nesbakken A, Larsen S, Dueland S, Edwin B, Bjørnbeth BA (2017)
    Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival
    Colorectal Dis, 19 (8), 731-738
    DOI 10.1111/codi.13622, PubMed 28181384
  6. Labori KJ, Lassen K, Hoem D, Grønbech JE, Søreide JA, Mortensen K, Smaaland R, Sorbye H, Verbeke C, Dueland S (2017)
    Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial
    BMC Surg, 17 (1), 94
    DOI 10.1186/s12893-017-0291-1, PubMed 28841916
  7. Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, Østrup O, Hovig E, Nygaard V, Rødland EA, Nakken S, Øien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Flørenes VA et al. (2017)
    Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
    ESMO Open, 2 (2), e000158
    DOI 10.1136/esmoopen-2017-000158, PubMed 28761742
  8. Van Laethem JL, Riess H, Jassem J, Haas M, Martens UM, Weekes C, Peeters M, Ross P, Bridgewater J, Melichar B, Cascinu S, Saramak P, Michl P, Van Brummelen D, Zaniboni A, Schmiegel W, Dueland S, Giurescu M, Garosi VL, Roth K, Schulz A, Seidel H, Rajagopalan P, Teufel M, Childs BH (2017)
    Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer
    Target Oncol, 12 (1), 97-109
    DOI 10.1007/s11523-016-0469-y, PubMed 27975152

Publications 2016

  1. Arnesen MR, Rekstad BL, Stokke C, Bruheim K, Løndalen AM, Hellebust TP, Malinen E (2016)
    Short-course PET based simultaneous integrated boost for locally advanced cervical cancer
    Radiat Oncol, 11, 39
    DOI 10.1186/s13014-016-0612-z, PubMed 26968827
  2. Dueland S, Ree AH, Grøholt KK, Saelen MG, Folkvord S, Hole KH, Seierstad T, Larsen SG, Giercksky KE, Wiig JN, Boye K, Flatmark K (2016)
    Oxaliplatin-containing Preoperative Therapy in Locally Advanced Rectal Cancer: Local Response, Toxicity and Long-term Outcome
    Clin Oncol (R Coll Radiol), 28 (8), 532-9
    DOI 10.1016/j.clon.2016.01.014, PubMed 26888115
  3. Flatmark K, Saelen MG, Hole KH, Abrahamsen TW, Fleten KG, Hektoen HH, Redalen KR, Seierstad T, Dueland S, Ree AH (2016)
    Individual tumor volume responses to short-course oxaliplatin-containing induction chemotherapy in locally advanced rectal cancer - Targeting the tumor for radiation sensitivity?
    Radiother Oncol, 119 (3), 505-11
    DOI 10.1016/j.radonc.2016.02.020, PubMed 26968754
  4. Frøysnes IS, Larsen SG, Spasojevic M, Dueland S, Flatmark K (2016)
    Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: Prognostic factors and oncologic outcome in a national patient cohort
    J Surg Oncol, 114 (2), 222-7
    DOI 10.1002/jso.24290, PubMed 27173150
  5. Kalanxhi E, Hektoen HH, Meltzer S, Dueland S, Flatmark K, Ree AH (2016)
    Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening
    BMC Cancer, 16, 536
    DOI 10.1186/s12885-016-2601-x, PubMed 27461255
  6. Kalanxhi E, Risberg K, Barua IS, Dueland S, Waagene S, Andersen SN, Pettersen SJ, Lindvall JM, Redalen KR, Flatmark K, Ree AH (2016)
    Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy
    Cancer Res Treat, 49 (2), 374-386
    DOI 10.4143/crt.2016.080, PubMed 27488871
  7. Kyte JA, Aamdal S, Dueland S, Sæbøe-Larsen S, Inderberg EM, Madsbu UE, Skovlund E, Gaudernack G, Kvalheim G (2016)
    Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
    Oncoimmunology, 5 (11), e1232237
    DOI 10.1080/2162402X.2016.1232237, PubMed 27999747
  8. Meltzer S, Kalanxhi E, Hektoen HH, Dueland S, Flatmark K, Redalen KR, Ree AH (2016)
    Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer
    Oncotarget, 7 (23), 34907-17
    DOI 10.18632/oncotarget.8995, PubMed 27145458

Publications 2015

  1. Arnesen MR, Knudtsen IS, Rekstad BL, Eilertsen K, Dale E, Bruheim K, Helland Å, Løndalen AM, Hellebust TP, Malinen E (2015)
    Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps
    Acta Oncol, 54 (9), 1607-13
    DOI 10.3109/0284186X.2015.1061690, PubMed 26213311

Publications 2014

  1. Arnesen MR, Bruheim K, Malinen E, Hellebust TP (2014)
    Spatial dosimetric sensitivity of contouring uncertainties in gynecological 3D-based brachytherapy
    Radiother Oncol, 113 (3), 414-9
    DOI 10.1016/j.radonc.2014.11.016, PubMed 25434766
  2. Guren MG, Undseth C, Rekstad BL, Brændengen M, Dueland S, Spindler KL, Glynne-Jones R, Tveit KM (2014)
    Reirradiation of locally recurrent rectal cancer: a systematic review
    Radiother Oncol, 113 (2), 151-7
    DOI 10.1016/j.radonc.2014.11.021, PubMed 25613395
  3. Ree AH, Meltzer S, Flatmark K, Dueland S, Kalanxhi E (2014)
    Biomarkers of treatment toxicity in combined-modality cancer therapies with radiation and systemic drugs: study design, multiplex methods, molecular networks
    Int J Mol Sci, 15 (12), 22835-56
    DOI 10.3390/ijms151222835, PubMed 25501337

Publications 2010

  1. Brændengen M, Tveit KM, Bruheim K, Cvancarova M, Berglund Å, Glimelius B (2010)
    Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study
    Int J Radiat Oncol Biol Phys, 81 (4), 1017-24
    DOI 10.1016/j.ijrobp.2010.07.007, PubMed 20932687
  2. Folkvord S, Flatmark K, Dueland S, de Wijn R, Grøholt KK, Hole KH, Nesland JM, Ruijtenbeek R, Boender PJ, Johansen M, Giercksky KE, Ree AH (2010)
    Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling
    Int J Radiat Oncol Biol Phys, 78 (2), 555-62
    DOI 10.1016/j.ijrobp.2010.04.036, PubMed 20675069
  3. Foss A, Adam R, Dueland S (2010)
    Liver transplantation for colorectal liver metastases: revisiting the concept
    Transpl Int, 23 (7), 679-85
    DOI 10.1111/j.1432-2277.2010.01097.x, PubMed 20477993
  4. Ree AH, Dueland S, Folkvord S, Hole KH, Seierstad T, Johansen M, Abrahamsen TW, Flatmark K (2010)
    Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
    Lancet Oncol, 11 (5), 459-64
    DOI 10.1016/S1470-2045(10)70058-9, PubMed 20378407

Publications 2009

  1. Borghaei H, Alpaugh K, Hedlund G, Forsberg G, Langer C, Rogatko A, Hawkins R, Dueland S, Lassen U, Cohen RB (2009)
    Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer
    J Clin Oncol, 27 (25), 4116-23
    DOI 10.1200/JCO.2008.20.2515, PubMed 19636016
  2. Bruheim K, Guren MG, Dahl AA, Skovlund E, Balteskard L, Carlsen E, Fosså SD, Tveit KM (2009)
    Sexual function in males after radiotherapy for rectal cancer
    Int J Radiat Oncol Biol Phys, 76 (4), 1012-7
    DOI 10.1016/j.ijrobp.2009.03.075, PubMed 19880263
  3. Bruheim K, Guren MG, Skovlund E, Hjermstad MJ, Dahl O, Frykholm G, Carlsen E, Tveit KM (2009)
    Late side effects and quality of life after radiotherapy for rectal cancer
    Int J Radiat Oncol Biol Phys, 76 (4), 1005-11
    DOI 10.1016/j.ijrobp.2009.03.010, PubMed 19540058

Publications 2008

  1. Bruheim K, Svartberg J, Carlsen E, Dueland S, Haug E, Skovlund E, Tveit KM, Guren MG (2008)
    Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH
    Int J Radiat Oncol Biol Phys, 70 (3), 722-7
    DOI 10.1016/j.ijrobp.2007.10.043, PubMed 18262088
  2. Larsen SG, Wiig JN, Emblemsvaag HL, Grøholt KK, Hole KH, Bentsen A, Dueland S, Vetrhus T, Giercksky KE (2008)
    Extended total mesorectal excision in locally advanced rectal cancer (T4a) and the clinical role of MRI-evaluated neo-adjuvant downstaging
    Colorectal Dis, 11 (7), 759-67
    DOI 10.1111/j.1463-1318.2008.01649.x, PubMed 18662240
  3. Ree AH, Bratland A, Dueland S (2008)
    [Molecular targeted therapy in colorectal cancer]
    Tidsskr Nor Laegeforen, 128 (2), 190-3
    PubMed 18202731

Publications 2007

  1. Larsen SG, Wiig JN, Dueland S, Giercksky KE (2007)
    Prognostic factors after preoperative irradiation and surgery for locally advanced rectal cancer
    Eur J Surg Oncol, 34 (4), 410-7
    DOI 10.1016/j.ejso.2007.05.012, PubMed 17614249
  2. Wiig JN, Dueland S, Larsen S, Giercksky KE (2007)
    [Treatment of locally recurrent rectal cancer]
    Tidsskr Nor Laegeforen, 127 (23), 3097-101
    PubMed 18049503
  3. Wiig JN, Larsen SG, Dueland S, Giercksky KE (2007)
    Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence
    Colorectal Dis, 10 (1), 48-57
    DOI 10.1111/j.1463-1318.2007.01398.x, PubMed 18028472

Publications 2006

  1. Guren MG, Tobiassen LB, Trygg KU, Drevon CA, Dueland S (2006)
    Dietary intake and nutritional indicators are transiently compromised during radiotherapy for rectal cancer
    Eur J Clin Nutr, 60 (1), 113-9
    DOI 10.1038/sj.ejcn.1602274, PubMed 16205744
  2. Kyte JA, Kvalheim G, Lislerud K, thor Straten P, Dueland S, Aamdal S, Gaudernack G (2006)
    T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells
    Cancer Immunol Immunother, 56 (5), 659-75
    DOI 10.1007/s00262-006-0222-y, PubMed 16947019
  3. Kyte JA, Mu L, Aamdal S, Kvalheim G, Dueland S, Hauser M, Gullestad HP, Ryder T, Lislerud K, Hammerstad H, Gaudernack G (2006)
    Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
    Cancer Gene Ther, 13 (10), 905-18
    DOI 10.1038/sj.cgt.7700961, PubMed 16710345

Publications 2005

  1. Sauer T, Guren MG, Noren T, Dueland S (2005)
    Demonstration of EGFR gene copy loss in colorectal carcinomas by fluorescence in situ hybridization (FISH): a surrogate marker for sensitivity to specific anti-EGFR therapy?
    Histopathology, 47 (6), 560-4
    DOI 10.1111/j.1365-2559.2005.02252.x, PubMed 16324192

Publications 2004

  1. Guren MG, Schneede J, Tveit KM, Ueland PM, Nexø E, Dueland S (2004)
    Biochemical signs of impaired cobalamin status during and after radiotherapy for rectal cancer
    Int J Radiat Oncol Biol Phys, 60 (3), 807-13
    DOI 10.1016/j.ijrobp.2004.04.018, PubMed 15465197

Publications 2003

  1. Dueland S, Guren MG, Olsen DR, Poulsen JP, Magne Tveit K (2003)
    Radiation therapy induced changes in male sex hormone levels in rectal cancer patients
    Radiother Oncol, 68 (3), 249-53
    DOI 10.1016/S0167-8140(03)00120-8, PubMed 13129632
  2. Dueland S, Sauer T, Lund-Johansen F, Ostenstad B, Tveit KM (2003)
    Epidermal growth factor receptor inhibition induces trichomegaly
    Acta Oncol, 42 (4), 345-6
    DOI 10.1080/02841860310006038, PubMed 12899508
  3. Guren MG, Dueland S, Skovlund E, Fosså SD, Poulsen JP, Tveit KM (2003)
    Quality of life during radiotherapy for rectal cancer
    Eur J Cancer, 39 (5), 587-94
    DOI 10.1016/S0959-8049(02)00741-4, PubMed 12628837

Publications 2001

  1. Dueland S, Wist E, Løberg M, Iversen J (2001)
    Cutaneous relapse of testicular embryonic carcinoma
    J Urol, 165 (3), 909
    DOI 10.1016/S0022-5347(05)66565-2, PubMed 11176507
  2. Guren MG, Wiig JN, Dueland S, Tveit KM, Fosså SD, Waehre H, Giercksky KE (2001)
    Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer
    Eur J Surg Oncol, 27 (7), 645-51
    DOI 10.1053/ejso.2001.1195, PubMed 11669593

Publications 2000

  1. Spitsen GM, Dueland S, Krisans SK, Slattery CJ, Miyake JH, Davis RA (2000)
    In nonhepatic cells, cholesterol 7alpha-hydroxylase induces the expression of genes regulating cholesterol biosynthesis, efflux, and homeostasis
    J Lipid Res, 41 (8), 1347-55
    PubMed 10946023

Publications 1998

  1. Dueland S, Stenwig AE, Heilo A, Høie J, Ous S, Fosså SD (1998)
    Treatment and outcome of patients with extragonadal germ cell tumours--the Norwegian Radium Hospital's experience 1979-94
    Br J Cancer, 77 (2), 329-35
    DOI 10.1038/bjc.1998.51, PubMed 9461006

Publications 1996

  1. Trawick JD, Lewis KD, Dueland S, Moore GL, Simon FR, Davis RA (1996)
    Rat hepatoma L35 cells, a liver-differentiated cell line, display resistance to bile acid repression of cholesterol 7 alpha-hydroxylase
    J Lipid Res, 37 (3), 588-98
    PubMed 8728321

Publications 1992

  1. Thrift RN, Drisko J, Dueland S, Trawick JD, Davis RA (1992)
    Translocation of apolipoprotein B across the endoplasmic reticulum is blocked in a nonhepatic cell line
    Proc Natl Acad Sci U S A, 89 (19), 9161-5
    PubMed 1409618

Publications 1991

  1. Leighton JK, Dueland S, Straka MS, Trawick J, Davis RA (1991)
    Activation of the silent endogenous cholesterol-7-alpha-hydroxylase gene in rat hepatoma cells: a new complementation group having resistance to 25-hydroxycholesterol
    Mol Cell Biol, 11 (4), 2049-56
    PubMed 2005896

Publications 1990

  1. Straka MS, Junker LH, Zacarro L, Zogg DL, Dueland S, Everson GT, Davis RA (1990)
    Substrate stimulation of 7 alpha-hydroxylase, an enzyme located in the cholesterol-poor endoplasmic reticulum
    J Biol Chem, 265 (13), 7145-9
    PubMed 2332427

Publications 1985

  1. Albrechtsen D, Helgerud P, Rugstad HE, Dueland S (1985)
    Very high concentration in intestinal lymph after oral, but not after intravenous, cyclosporine in the rat
    Transplantation, 40 (2), 220-2
    DOI 10.1097/00007890-198508000-00025, PubMed 4024244
  2. Dueland S, Bouillon R, Van Baelen H, Pedersen JI, Helgerud P, Drevon CA (1985)
    Binding protein for vitamin D and its metabolites in rat mesenteric lymph
    Am J Physiol, 249 (1 Pt 1), E1-5
    DOI 10.1152/ajpendo.1985.249.1.E1, PubMed 2990230

Publications 1984

  1. Blomhoff R, Helgerud P, Dueland S, Berg T, Pedersen JI, Norum KR, Drevon CA (1984)
    Lymphatic absorption and transport of retinol and vitamin D-3 from rat intestine. Evidence for different pathways
    Biochim Biophys Acta, 772 (2), 109-16
    DOI 10.1016/0005-2736(84)90033-6, PubMed 6326820

Publications 1983

  1. Dueland S, Helgerud P, Pedersen JI, Berg T, Drevon CA (1983)
    Plasma clearance, transfer, and distribution of vitamin D3 from intestinal lymph
    Am J Physiol, 245 (4), E326-31
    DOI 10.1152/ajpendo.1983.245.4.E326, PubMed 6312805
  2. Dueland S, Pedersen JI, Helgerud P, Drevon CA (1983)
    Absorption, distribution, and transport of vitamin D3 and 25-hydroxyvitamin D3 in the rat
    Am J Physiol, 245 (5 Pt 1), E463-7
    DOI 10.1152/ajpendo.1983.245.5.E463, PubMed 6314821

Publications 1982

  1. Davis RA, Helgerud P, Dueland S, Drevon CA (1982)
    Evidence that reverse cholesterol transport occurs in vivo and requires lecithin-cholesterol acyltransferase
    Biochim Biophys Acta, 689 (2), 410-4
    DOI 10.1016/0005-2736(82)90276-0, PubMed 7115718
  2. Dueland S, Pedersen JI, Drevon CA, Björkhem I (1982)
    26-hydroxylation of 5 beta-cholestane-3 alpha,7 alpha,12 alpha-triol by isolated nonparenchymal cells and hepatocytes from rat liver
    J Lipid Res, 23 (9), 1321-7
    PubMed 7161561
  3. Dueland S, Pedersen JI, Helgerud P, Drevon CA (1982)
    Transport of vitamin D3 from rat intestine. Evidence for transfer of vitamin D3 from chylomicrons to alpha-globulins
    J Biol Chem, 257 (1), 146-50
    PubMed 6171567
  4. Hansen CE, Dueland S, Drevon CA, Størmer FC (1982)
    Metabolism of ochratoxin A by primary cultures of rat hepatocytes
    Appl Environ Microbiol, 43 (6), 1267-71
    PubMed 7103484

Publications 1981

  1. Dueland S, Holmberg I, Berg T, Pedersen JI (1981)
    Uptake and 25-hydroxylation of vitamin D3 by isolated rat liver cells
    J Biol Chem, 256 (20), 10430-4
    PubMed 6270111
  2. DUELAND S, HOLMBERG I, BERG T, PEDERSEN JI (1981)
    UPTAKE AND 25-HYDROXYLATION OF VITAMIN-D3 BY ISOLATED RAT-LIVER CELLS
    J. Biol. Chem., 256 (20), 430-434

 
Page visits: 70